Error: Could not add to watchlist. X
+ Watchlist

RXi Pharmaceuticals Corp

RXII:US
NASDAQ CM
1.986
USD
0.064
3.12%
As of 8:10 PM EDT 9/23/2016
Open
2.030
Day Range
1.970 - 2.040
Volume
18,357
Previous Close
2.050
52Wk Range
1.260 - 6.494
1 Yr Return
-50.47%
Open
2.030
Day Range
1.970 - 2.040
Volume
18,357
Previous Close
2.050
52Wk Range
1.260 - 6.494
1 Yr Return
-50.47%
YTD Return
-48.01%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-4.540
Market Cap (m USD)
13.029
Shares Outstanding (m)
6.560
Price/Sales (TTM)
119.07
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
RXi Pharmaceuticals Corp. is a biotechnology company focused on discovering, developing and commercialization therapies addressing major unmet medical needs using RNAI-targeted technologies. The Company's proprietary RNA interference is a naturally occurring cellular mechanism that interferes with and silences expression of targeted disease-associated genes.
Address
60 Prescott Street
Worcester, MA 01605
United States
Phone
1-508-767-3861
Show More